Dysregulation of glutaminase and glutamine synthetase in cancer

José M Matés1, José A Campos-Sandoval1, Juan de Los Santos-Jiménez1

  • 1Department of Molecular Biology and Biochemistry, Canceromics Lab, Faculty of Sciences, Campus de Teatinos, University of Málaga, 29071, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA), Málaga, Spain.

Cancer Letters
|October 2, 2019
PubMed

Insights

Cancer cells consume elevated glutamine, driving tumor growth. Combination therapies targeting glutamine metabolism and the tumor microenvironment are crucial for overcoming cancer resistance.

Area of Science:

  • Oncology
  • Cancer Metabolism
  • Biochemistry

Background:

  • Many cancers exhibit rapid glucose breakdown and increased glutamine uptake.
  • Targeting cancer cell metabolism, particularly glycolysis and glutaminolysis, is a key medical oncology strategy.
  • Tumor cells develop adaptive resistance to metabolic inhibitors, necessitating advanced therapeutic approaches.

Purpose of the Study:

  • To explore the role of glutamine metabolism in cancer development and resistance.
  • To evaluate combination therapies for overcoming cancer growth and metabolic resistance.
  • To investigate the potential of targeting glutaminase, glutamine synthetase, and the tumor microenvironment.

Main Methods:

  • Analysis of cancer cell metabolic pathways, focusing on glucose and glutamine.
  • Review of therapeutic strategies involving inhibitors of glutamine metabolism enzymes (glutaminase, glutamine synthetase).
  • Consideration of combination therapies and targeting the tumor microenvironment.

Main Results:

  • Dysregulation of glutaminase and glutamine synthetase facilitates tumor anabolic adaptation.
  • Specific drugs inhibiting glutamine metabolism enzymes have shown efficacy against certain neoplasms.
  • Combination therapy presents a synergistic approach to combat cancer growth and resistance.

Conclusions:

  • Targeting glutamine metabolism is essential for controlling cancer progression.
  • Combination therapies and targeting the tumor microenvironment are vital for overcoming treatment resistance.
  • Further research into metabolic pathway inhibition and combination strategies is warranted.

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.8K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Biosynthesis of Nucleic Acids01:28

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...
898
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.6K
Overview of Protein Metabolism01:21

Overview of Protein Metabolism

Proteins are broken down into amino acids during digestion. Unlike fats and carbohydrates, which are stored for later use, proteins are not. Instead, amino acids are either used to produce ATP through oxidation or contribute to the creation of new proteins for the growth and repair of the body. Any surplus amino acids from the diet are converted into glucose or triglycerides rather than excreted.
Amino acids play various roles in the body once they are absorbed into cells. They are restructured...
3.5K